Skip to main content
QXL Diagnostics
Infectious Diseases & Fever Diagnostics Verified Clinical Guide

Dengue NS1, IgM, IgG or PCR: Which Dengue Test Is Appropriate and When?

Clinically Reviewed by Dr. Shantakumar Muruda, MD (Medical Biochemistry)Head of Biochemistry · QXL Diagnostics (NABL Lab MC-6849)
November 19, 2026
5 min read
10 Sections
Dengue NS1, IgM, IgG or PCR: Which Dengue Test Is Appropriate and When? - QXL Diagnostics Bengaluru
Share Clinical Guide:
Dengue diagnostic accuracy depends entirely on the day of fever. Ordering NS1 antigen on day 8 or antibody tests on day 1 produces dangerously misleading false negatives. Learn which test matches your day of illness and critical warning signs requiring hospitalization.

💡 AI Direct Answer: When is Dengue NS1 testing most useful?#

Direct Clinical Answer: Dengue NS1 antigen testing is primarily useful during the early acute viremic phase of illness—specifically during the first 5 to 7 days after the onset of fever. Because the dengue virus actively replicates and sheds the non-structural protein 1 (NS1) into the bloodstream during this window, NS1 provides rapid, highly specific confirmation. Testing for NS1 after Day 7 is clinically inappropriate because rising host antibodies clear free circulating antigen, leading to false-negative results.


Dengue fever, caused by four distinct flavivirus serotypes (DENV-1, DENV-2, DENV-3, DENV-4) transmitted by Aedes aegypti mosquitoes, is endemic throughout Bengaluru.

A frequent clinical mistake is selecting a dengue test based on generic diagnostic names without considering the exact day of fever. Ordering an antibody test on Day 2 will be falsely negative because the host immune system has not yet mounted a humoral response. Conversely, ordering an NS1 antigen test on Day 9 will be falsely negative because viremia has resolved.


Dengue Diagnostic Timeline by Day of Fever#

Illness PhaseDay of IllnessPrimary Diagnostic MarkersRecommended Laboratory Tests
Early Acute Viremic PhaseDays 1 to 5Dengue Viral RNA & Soluble NS1 GlycoproteinDengue NS1 Antigen (ELISA) OR Dengue RT-PCR + CBC for Platelets & Hematocrit
Transition / Critical PhaseDays 5 to 7NS1 declining; Host IgM antibodies emergingDengue Duo Panel (NS1 Antigen + Dengue IgM Antibody) + Serial CBC monitoring
Late Convalescent PhaseDay 8 onwardsNS1 negative; IgM peak; IgG risingDengue IgM & IgG Antibody Chemiluminescence

What is NS1 Antigen?#

Non-Structural Protein 1 (NS1) is a 46–55 kDa glycoprotein essential for viral replication and immune evasion. During acute infection, infected monocytes and hepatocytes secrete massive hexameric complexes of NS1 into the bloodstream.

  • Diagnostic Strength: High specificity (> 95%). A positive NS1 test during the first 5 days confirms dengue infection with near certainty.
  • Analytical Limitation: Sensitivity is approximately 75–85%. Up to 20% of infected patients can test falsely negative, especially in secondary infections where pre-existing IgG antibodies cross-react and bind up free NS1 antigen into immune complexes.

Understanding Dengue IgM and IgG Antibodies#

  1. Dengue IgM Antibodies: IgM appears around Day 4 to Day 5 of fever as the primary immune response, peaking at approximately Day 10 to 14, and remains detectable for 60 to 90 days. A positive IgM in a patient with recent fever indicates acute or recent dengue.
  2. Dengue IgG Antibodies: In primary dengue (first lifetime infection), IgG emerges slowly around Day 10 to 14 and persists for life, conferring long-term immunity only against that specific serotype. In secondary dengue (infection with a different serotype), IgG rises exponentially within 24–48 hours, often while IgM remains low.

Critical Hematology Monitoring: Platelets & Hematocrit#

While serological and molecular assays confirm the virus, they do not assess clinical severity. Management of dengue requires serial monitoring of Complete Blood Count (CBC):

  • Thrombocytopenia (Platelet Drop): Platelet counts often decline rapidly between Days 3 and 7. However, platelets alone do not cause fatal complications.
  • Hematocrit (Packed Cell Volume - PCV): The true physiological danger in dengue is capillary plasma leakage. As plasma leaks from microvessels into peritoneal and pleural spaces, intravascular fluid drops, concentrating red blood cells and driving hematocrit upward.
  • The Red-Flag Signal: A rising hematocrit (> 20% above baseline) coupled with a rapidly falling platelet count is the definitive hallmark of plasma leakage and impending Dengue Shock Syndrome (DSS).

Dengue Warning Signs: When to Seek Emergency Hospitalization#

Do not wait for a repeat laboratory report if any of the following WHO warning signs develop:

  • Severe, persistent abdominal pain or tenderness;
  • Persistent vomiting (unable to tolerate oral fluids);
  • Mucosal bleeding (bleeding gums, epistaxis, red/black stools, prolonged menstrual bleeding);
  • Lethargy, restlessness, confusion, or extreme drowsiness;
  • Cold, clammy extremities with a rapid, weak pulse (signs of circulatory collapse);
  • Difficulty breathing due to pleural fluid accumulation.

Diagnostic Fever Testing at QXL Diagnostics#


Frequently Asked Questions#

Can dengue be cured with antibiotics?#

No. Dengue is caused by a virus. Antibiotics have zero activity against viruses and should never be taken empirically for dengue.

Does drinking papaya leaf juice cure dengue?#

While small studies suggest papaya leaf extract may modestly support platelet counts, it does not stop plasma leakage. Intravenous fluid management and clinical monitoring are the only proven life-saving interventions for severe dengue.


Clinical References & Guidelines#

  1. World Health Organization (WHO). Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: WHO; 2020.
  2. National Center for Vector Borne Diseases Control (NCVBDC). National Guidelines for Clinical Management of Dengue Fever. Ministry of Health and Family Welfare, India; 2023.
  3. Centers for Disease Control and Prevention (CDC). Dengue Clinical Guidance for Healthcare Providers. 2024.

Medical information notice: This article is for general educational purposes and does not diagnose disease or replace consultation with a qualified healthcare professional. Test selection, preparation and interpretation should be based on individual clinical circumstances.

Medical & Laboratory Disclaimer

Medical information notice: This article is for general educational purposes and does not diagnose disease or replace consultation with a qualified healthcare professional. Test selection, preparation and interpretation should be based on individual clinical circumstances.

Medically Reviewed & Fact-Checked Reviewed: November 19, 2026

Dr. Shantakumar Muruda, MD (Medical Biochemistry)

Head of Clinical Biochemistry & Quality Management, QXL Diagnostics Bengaluru (NABL Accredited Laboratory MC-6849). Trained Lead Assessor for ISO 15189:2022 medical laboratory standards.

QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.

Share Clinical Guide:

Related Clinical Guides

Explore more evidence-based diagnostic articles and testing guidelines